Skip to content
Saturday, September 23, 2023
Staff Email
FAQs
facebook
twitter
MCAZ
Protecting your right to human medicines and medical devices
Search the website...
MENU
MENU
MENU
MENU
Home
About Us
Who We Are
MCAZ Board Members
Corporate Governance
Tenders
Careers @ MCAZ
Privacy Policy
Client Service Charter
Board Charter
Regulatory Functions
Evaluation and Registration
Overview
Find A Registered Medicine
How to Register
Alternative Submission Pathways
Registered & Approved Medicines
Human Medicines Guidelines
Key timelines for the Evaluation and Registration
Important Information
Summary for Product Characteristics
Licensing and Enforcement
Overview
Licensing
Inspections
Import & Export
Product Defects & Recalls
Medicinal Cannabis
Enquiries
Pharmacovigilance and Clinical Trials
Current Projects
Pharmacovigilance Centre
Clinical Trials
WHO Pharmacovigilance Toolkit
Clinical Trial Public Registry Platform
Laboratory Services
Medical Devices Laboratory
Microbiology Laboratory
Chemistry Laboratory
Legal and Coperate Affairs
Overview
Procurement Section
Tenders
Request For Quotations
Online Services
Online Registers
ADR E-Reporting
Consumer Reporting
Healthcare Professional Reporting
Import/Export for Registered Medicines
e-Clinical Trials
Online Persons and Premises Renewals
Section 75 Authorisation
Publications
Annual Reports
Press Release
Vaccine Safety
Downloads
RCore Trainings
Contact Us
MCAZ Guideline on Biowaivers
MCAZ Guideline on Biowaivers
979
Downloads
DOWNLOAD
Size:
73KB
Top
